SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001493152-20-008180
Filing Date
2020-05-11
Accepted
2020-05-11 10:51:57
Documents
87
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form6ka.htm 6-K/A 23868
2 ex99-1.htm EX-99.1 429342
3 ex99-2.htm EX-99.2 230039
4 ex99-2_001.jpg GRAPHIC 8650
5 ex99-3.htm EX-99.3 15608
6 ex99-4.htm EX-99.4 15299
  Complete submission text file 0001493152-20-008180.txt   4148109

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE aezs-20200331.xml EX-101.INS 753188
8 XBRL SCHEMA FILE aezs-20200331.xsd EX-101.SCH 66060
9 XBRL CALCULATION FILE aezs-20200331_cal.xml EX-101.CAL 85418
10 XBRL DEFINITION FILE aezs-20200331_def.xml EX-101.DEF 192032
11 XBRL LABEL FILE aezs-20200331_lab.xml EX-101.LAB 374113
12 XBRL PRESENTATION FILE aezs-20200331_pre.xml EX-101.PRE 288173
Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2
Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201
Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-38064 | Film No.: 20863232
SIC: 2834 Pharmaceutical Preparations